Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-08-23FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Accord Healthcare Inc.)
The FDA approved a supplemental application for Montelukast Sodium submitted by Accord Healthcare Inc. The snippet does not specify the exac…
-
FDA approval · 2013-08-06FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Montelukast Sodium from Dr. Reddy's Laboratories Limited under an ANDA.
-
FDA approval · 2013-08-06FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
FDA approved a supplemental application for Montelukast Sodium submitted by Dr. Reddy's Laboratories Limited.
-
FDA approval · 2013-07-23FDA Approved: CLARINEX — Supplemental Application (Organon LLC)
FDA has approved a supplemental application for CLARINEX (desloratadine) submitted by Organon LLC.
-
FDA approval · 2013-07-02FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for NASACORT ALLERGY 24HR (triamcinolone acetonide) from Chattem, Inc., indicating an update to …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-06-05FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
The FDA approved a supplemental application for Claritin (loratadine) submitted by Bayer HealthCare LLC.
-
FDA approval · 2013-05-28FDA Approved: CHILDRENS CETIRIZINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for Children's Cetirizine Hydrochloride from Sun Pharmaceutical Industries, Inc. This action exp…
-
FDA approval · 2013-05-24FDA Approved: NASACORT ALLERGY 24HR — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for NASACORT ALLERGY 24HR (triamcinolone acetonide) from Chattem, expanding its labeling.
-
FDA approval · 2013-04-28FDA Approved: CHILDRENS ALLEGRA ALLERGY — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for Children's Allegra Allergy (fexofenadine hydrochloride) from Chattem, Inc., related to its use i…
-
FDA approval · 2013-04-26FDA Approved: CLARITIN-D 24 HOUR — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved a supplemental application for Claritin-D 24 Hour (loratadine and pseudoephedrine sulfate) submitted by Bayer HealthCare LL…
-
FDA approval · 2013-04-04FDA Approved: CROMOLYN SODIUM — Original Application (Micro Labs Limited)
FDA approved Micro Labs Limited's original ANDA for cromolyn sodium.
-
FDA approval · 2013-03-26FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved Bayer's supplemental application to add a Claritin chewable grape and bubblegum formulation containing loratadine. This exp…
-
FDA approval · 2013-03-26FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for DYMISTA (azelastine hydrochloride and fluticasone propionate) filed by Viatris Specialty LLC…
-
FDA approval · 2013-03-13FDA Approved: CLARITIN-D 12 HOUR — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for Claritin-D 12 Hour, a combination of loratadine and pseudoephedrine sulfate.
-
FDA approval · 2013-03-13FDA Approved: AZELASTINE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for azelastine hydrochloride from Apotex Corp., as indicated by the FDA's 'AP' submission status for…
-
FDA approval · 2013-02-28FDA Approved: CLARITIN ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved Bayer HealthCare LLC's supplemental application for Claritin Allergy (loratadine). This action covers changes related to th…
-
FDA approval · 2013-02-13FDA Approved: CLARITIN-D 24 HOUR — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for CLARITIN-D 24 HOUR (loratadine and pseudoephedrine sulfate) from Bayer HealthCare LLC.
-
FDA approval · 2013-02-05FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for montelukast sodium submitted by Dr. Reddy's Laboratories Limited. The approval extends the r…
-
FDA approval · 2013-02-05FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark Pharmaceuticals Inc., USA's supplemental application for levocetirizine dihydrochloride, a generic antihistamine u…
-
FDA approval · 2013-01-30FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Camber Pharmaceuticals' generic levocetirizine dihydrochloride.
-
FDA approval · 2013-01-28FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for Montelukast Sodium from Torrent Pharmaceuticals Limited. This action confirms continued mark…
-
FDA approval · 2013-01-28FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental ANDA for a generic montelukast sodium product submitted by Torrent Pharmaceuticals Limited.
-
FDA approval · 2013-01-04FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add a grape and bubblegum flavor for Claritin chewable (loratadine) manufactured by Bayer HealthC…
-
FDA approval · 2013-01-02FDA Approved: FEXOFENADINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The U.S. FDA approved a supplemental application for fexofenadine hydrochloride from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2012-12-30FDA Approved: PROMETHEGAN — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Cosette Pharmaceuticals' PROMETHEGAN (promethazine hydrochloride), updating its labeling und…